Our Story

Kaizhi Biotherapeutics is a clinical-stage biotechnology company dedicated to the discovery and development of innovative therapies for oncology and immunology indications.

The company integrates deep biological insights with translational research and clinical development capabilities to advance differentiated therapeutic programs from early discovery through clinical evaluation.

With a focus on precision medicine and biomarker-driven strategies, Kaizhi aims to deliver targeted therapies that address significant unmet medical needs in China and globally.

Laboratory scientist examining cellular samples under a microscope in a modern biotech facility.
Laboratory scientist examining cellular samples under a microscope in a modern biotech facility.
Learn More
Global map highlighting Kaizhi Biotherapeutics’ partnerships across Asia, Europe, and North America.
Global map highlighting Kaizhi Biotherapeutics’ partnerships across Asia, Europe, and North America.
Close-up of clinical trial data displayed on a digital tablet in a clean, clinical setting.
Close-up of clinical trial data displayed on a digital tablet in a clean, clinical setting.

Our Mission

To discover, develop, and deliver transformative therapies that address serious diseases with high unmet need — guided at every step by scientific integrity, clinical relevance, and respect for patients.

Our Vision

A world in which every patient with a serious disease has access to a therapy precisely designed for their biology.

Our Values

Minimalist icon representing scientific research with clean lines and a molecular structure.
Minimalist icon representing scientific research with clean lines and a molecular structure.
Intellectual Courage

We pursue what’s difficult. We question consensus. We welcome challenge.

Collaborative Excellence

The best science happens at intersections. We build bridges across disciplines, institutions, and geographies.

What We Stand For...

Our core values guide every step in advancing biotechnology with precision and care.

Scientific Rigor

We trust data above assumption. Every program earns its advancement through evidence.

Patient Primacy

Every decision from target selection to clinical design is made with patients first.

Pipeline

Advancing targeted therapies through clinical stages.

A detailed laboratory setting showing scientists analyzing molecular structures on computer screens.
A detailed laboratory setting showing scientists analyzing molecular structures on computer screens.
Key Programs

Our lead oncology and immunology candidates are progressing with biomarker-driven strategies to optimize patient outcomes across global trials.

Clinical researchers discussing patient data charts in a modern conference room with international maps on the wall.
Clinical researchers discussing patient data charts in a modern conference room with international maps on the wall.
Collaborations

Partnering with institutions across Asia, Europe, and North America to accelerate translational research and expand therapeutic impact.

Interested in Partnering With Us?

We welcome conversations with academic institutions, clinical investigators, biopharma partners, and investors who share our commitment to transforming medicine.

Reach out for scientific collaborations or inquiries

Email

info@kaizhibio.com

© 2025. All rights reserved.

Contact Us